Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Derya KIVRAK SALİM"'
Autor:
Mustafa Ozgur Arici, Derya Kivrak Salim, Murat Kocer, Ahmet Sukru Alparslan, Baris Rafet Karakas, Banu Ozturk
Publikováno v:
Medicina, Vol 60, Iss 11, p 1849 (2024)
Background and Objectives: Neoadjuvant chemotherapy (NAC) improves survival by increasing pathologic complete response (pCR). Blood-based indexes have been studied in breast cancer for predicting pCR and prognosis, but the results are conflicting. We
Externí odkaz:
https://doaj.org/article/b45c69d582824e2fac5e49087419ff1c
Autor:
Arif Hakan Onder, Banu Ozturk, Murat Kocer, Deniz Ozbay Gediz, Derya Kivrak Salim, Mustafa Yildiz, Selami Bayram, Sevil Goktas
Publikováno v:
Medicine Science, Vol 12, Iss 3, Pp 827-52 (2023)
The aim of this study is to determine the discrepancy and agreement between Eastern Cooperative Oncology Group Performance Status (ECOG-PS) scores evaluated by doctors and patients and examine the factors that influence the performance evaluation of
Externí odkaz:
https://doaj.org/article/69b5fb7a86fd46b99e2afca49d9a1cce
Autor:
Arif Hakan ONDER, Derya KIVRAK SALİM, Mustafa KARACA, Selami BAYRAM, Armağan AYDIN, Sevil GÖKTAŞ, Murat KOÇER, Deniz ÖZBAY GEDİZ, Mustafa YILDIZ, Banu ÖZTÜRK
Publikováno v:
Volume: 44, Issue: 4 384-389
Cumhuriyet Tıp Dergisi
Cumhuriyet Medical Journal
Cumhuriyet Tıp Dergisi
Cumhuriyet Medical Journal
İntroduction and aim: Cancer affects people psychologically and organically. The emotional state of cancer patients is fragile and can be affected by many factors. We aimed to evaluate the effect of the Covid-19 pandemic on the mood and behavioral c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a899aeff6854bbc60d8d81c9244488d6
https://dergipark.org.tr/tr/pub/cmj/issue/74897/1210488
https://dergipark.org.tr/tr/pub/cmj/issue/74897/1210488
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311678
Background Leukocytoclastic vasculitis (LCV) is a vasculitic inflammation against blood vessels. Various anticancer therapies can cause vasculitis, but capecitabine-induced LCV is an unusual entity. Here, we describe an LCV case associated with neoad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1903ffe4815e43e24156ffb0ac9ba27
https://doi.org/10.1177/10781552231167812
https://doi.org/10.1177/10781552231167812
Autor:
Özlem Özdemir, Baha Zengel, Yaşar Yildiz, Basak Oyan Uluç, Devrim Cabuk, Ercan Ozden, Derya Kivrak Salim, Semra Paydas, Atakan Demir, Omer Diker, Kezban Nur Pilanci, Özlem Uysal Sönmez, Sezai Vatansever, Izzet Dogan, Ahmet Gulmez, Burcu Cakar, Pinar Gursoy, Mahmut Emre Yildirim, Murat Ayhan, Nuri Karadurmus, Musa Baris Aykan, Gökcen Tugba Cevik, Teoman Sakalar, Ilhan Hacibekiroglu, Burcu Belen Gülbagci, Murat Dincer, Duygu Bayir Garbioglu, Yasemin Kemal, Erdinc Nayir, Halil Taskaynatan, Mesut Yilmaz, Okan Avci, Murat Sari, Ezgi Coban, Muhammed Mustafa Atci, Selin Aktürk Esen, Tugba Akin Telli, Fatih Karatas, Ali Inal, Hacer Demir, Nurhan Onal Kalkan, Cengiz Yilmaz, Funda Tasli, Ahmet Alacacioglu
In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted by the Turkish Oncology G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::934c684ccacc5bd283fae448009bb29f
https://hdl.handle.net/11454/77368
https://hdl.handle.net/11454/77368
Autor:
Elvina Almuradova, irem öner, Murat Ayhan, Emre Yekedüz, Esma Turkmen Bekmez, Devrim Cabuk, Ahmet Gulmez, miraç özen, Melike Ozcelik, elif şenocak taşçı, Murat Dincer, Turgut Kaçan, Özgecan Dülgar, Ozlem Ozdemir, Melek Karakurt Eryilmaz, Ozkan Alan, Hasan Cagri Yildirim, Ebru Cilbir, Berna Öksüzoğlu, Serdar Turhal, Tugba Basoglu, Nazan Demir, Naziye Ak, Yusuf Karakas, Mutlu Dogan, Deniz Tataroğlu Özyükseler, Ali Inal, Abdullah Sakin, çağlar ünal, Ilhan Hacibekiroglu, Gulhan Ipek Deniz, Perran Fulden Yumuk, Dilek Erdem, Mehmet Ali Nahit Sendur, Cihan Erol, Suayib Yalcin, nelihan doğan, Bulent Karabulut, Ercan Ozden, Abdilkerim Oyman, Ozlem Er, Semra Paydas, Derya Kivrak Salim, Asude Aksoy
PurposeNeoadjuvant chemotherapy(NACT) in gastroesophageal junction(GEJ) and gastric cancer(GC) was shown to improve survival in recent studies. We aimed to share our real-life experience of patients who received NACT in order to compare the efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6d1eb63553c52367c6638ae07976dfd
https://doi.org/10.21203/rs.3.rs-884239/v1
https://doi.org/10.21203/rs.3.rs-884239/v1
Autor:
Elif Şenocak Taşçi, Basak Oyan, Ozlem Sonmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Irem Oner, Havva Yesil Cinkir, Melek Karakurt Eryılmaz, Onur Yazdan Balçık, Nail Paksoy, Derya Kivrak Salim, Mirac Özen, Melike Ozcelik, Ali Arican, Ali Inal, Baran Akagunduz, Dinçer Aydın, Leyla Ozer, Nazim Serdar Turhal, Ahmet Gulmez
Publikováno v:
Journal of Clinical Oncology. 40:202-202
202 Background: The optimal treatment for metastatic colorectal cancer (mCRC) after the second line is still controversial. Regorafenib (Reg) revealed promising results by improving overall survival compared to best supportive care. However, in real-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53bafb1d3de0a410579a00fc45d7f57e
https://doi.org/10.1200/jco.2022.40.4_suppl.202
https://doi.org/10.1200/jco.2022.40.4_suppl.202
Autor:
Fatma Yalçin Müsri, Betül Ünal, Hasan Şenol Coşkun, Derya Kivrak Salim, Melek Karakurt Eryilmaz, Hasan Mutlu
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 14, Iss 3, Pp 619-624 (2018)
Objective: Increased tumor-infiltrating lymphocytes (TILs) in breast carcinoma tissues is an independent predictive factor for pathologic complete response (pCR). The increased intratumoral and stromal TILs (sTILs) in breast cancer (BC) have signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e40f08984508ebea5101f08e8ce8ad3
http://www.cancerjournal.net/article.asp?issn=0973-1482
http://www.cancerjournal.net/article.asp?issn=0973-1482
Autor:
Derya Kivrak Salim
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 25(8)
Hemangioblastomas of central nervous system are rare and indolent. Twenty-five percent of cases are in association with von Hippel–Lindau disease. Surgery is the standard therapy but un-resectable or recurrent cases need radiation or systemic thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::956ef8bbf276b8c59e449eaf21dde66b
https://pubmed.ncbi.nlm.nih.gov/31694494
https://pubmed.ncbi.nlm.nih.gov/31694494
Autor:
Fatma Yalçin Müsri, Melek Karakurt Eryilmaz, Hasan Mutlu, Gokhan Tazegul, Derya Kivrak Salim, Hasan Şenol Coşkun
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 15, Iss 8, Pp 170-172 (2019)
Renal pelvis squamous cell carcinoma (RSCC) is a rare tumor. It starts with nonspecific symptoms and it is usually at an advanced stage with a poor prognosis at the time of diagnosis. SCC-associated hypercalcemia is a well-known paraneoplastic syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c90bf93d9107fdab2f032ca874c2b99a
https://pubmed.ncbi.nlm.nih.gov/30900642
https://pubmed.ncbi.nlm.nih.gov/30900642